Transpact Enterprises Ltd - Stock Valuation and Financial Performance

BSE: 542765 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Transpact Enterprise Share Price

394.20 0.00 0.00%
as on 27-Mar'24 16:01

DeciZen - make an informed investing decision on Transpact Enterprise

M-Cap below 100cr DeciZen not available

Transpact Enterprises stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
15.2 Cr.
52-wk low:
114
52-wk high:
483.8

Is Transpact Enterprises Ltd an attractive stock to invest in?

1. Is Transpact Enterprises Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Transpact Enterprises Ltd is a below average quality company.

2. Is Transpact Enterprises Ltd undervalued or overvalued?

The key valuation ratios of Transpact Enterprises Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Transpact Enterprises Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transpact Enterprises Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Transpact Enterprise:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Transpact Enterprises Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -19.5%-27.6%-69%-54.8%-5.7%-22%-7.7%-
Value Creation
Index
-2.4-3.0-5.9-4.9-1.4-2.6-1.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 000.1000.20.40
Sales YoY Gr.-NANA-100%NA400%153.3%-
Adj EPS -1.6-3.2-10.6-11.2-1.7-5.7-1.7-1.7
YoY Gr.-NANANANANANA-
BVPS (₹) 5.82.60.122.921.215.513.813.8
Adj Net
Profit
-0.1-0.1-0.3-0.4-0.1-0.2-0.10
Cash Flow from Ops. -0.1-0.10.1-1.10-0.90-
Debt/CF from Ops. -1.4-0.92.8-0.226.2-0.332.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA153.3%
Adj EPS NANANANA
BVPSNA39.9%-15.5%-11%
Share Price - - 34.5% 315%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-27.6-37.6-103.9-76.3-7.5-31.1-11.6-12.3
Op. Profit
Mgn %
00-202.90-195.7-138.5-7.8NAN
Net Profit
Mgn %
00-229.50-256.7-147.3-17.2-17.5
Debt to
Equity
0.40.30.70.30.40.50.5-
Working Cap
Days
00386014,8862,3077990
Cash Conv.
Cycle
0016602,10546-740

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Transpact Enterprises Ltd.

Standalone Consolidated
TTM EPS (₹) -1.7 -
TTM Sales (₹ Cr.) 0.4 -
BVPS (₹.) 13.8 -
Reserves (₹ Cr.) - -
P/BV 28.58 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 114.00 / 483.80
All Time Low / High (₹) 86.00 / 483.80
Market Cap (₹ Cr.) 15.2
Equity (₹ Cr.) 0.4
Face Value (₹) 10
Industry PE 59.1

Management X-Ray of Transpact Enterprise:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Transpact Enterprise

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales000.1300.030.150.38
Operating Expenses 0.050.090.390.410.070.360.41
Manufacturing Costs000.010000.01
Material Costs000.09000.280.19
Employee Cost 0.010.040.010.020.030.040.11
Other Costs 0.030.050.270.390.050.050.10
Operating Profit -0.05-0.09-0.26-0.41-0.05-0.21-0.03
Operating Profit Margin (%) ---202.0%--195.0%-138.0%-7.8%
Other Income 0000.020.030.030
Interest 0000000
Depreciation 000.020.040.040.040.04
Exceptional Items 0000000
Profit Before Tax -0.05-0.09-0.29-0.42-0.06-0.22-0.07
Tax 000.010.010.0100
Profit After Tax -0.05-0.09-0.30-0.43-0.06-0.22-0.07
PAT Margin (%) ---229.0%--256.0%-147.0%-17.2%
Adjusted EPS (₹)-1.6-3.2-10.6-11.2-1.7-5.7-1.7
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 0.160.320.250.880.820.600.53
Share Capital 0.040.290.290.390.390.390.39
Reserves 0.120.03-0.040.500.430.210.15
Minority Interest0000000
Debt0.070.110.180.260.290.290.28
Long Term Debt0000000
Short Term Debt0.070.110.180.260.290.290.28
Trade Payables00.040.050.110.090.100.06
Others Liabilities 000.030.050.180.110.17
Total Liabilities 0.240.470.521.311.381.101.04

Fixed Assets

Gross Block0.180.180.370.370.370.370.37
Accumulated Depreciation000.020.060.100.130.17
Net Fixed Assets0.180.180.350.310.270.240.20
CWIP 00.1200000
Investments 0000000
Inventories00.090.090.180.180.010.01
Trade Receivables000.030000
Cash Equivalents 0.010.060.010.010.050.020.01
Others Assets0.050.020.050.800.870.830.82
Total Assets 0.240.470.521.311.381.101.04

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.05-0.110.07-1.140.01-0.870.01
PBT -0.05-0.09-0.29-0.42-0.06-0.22-0.07
Adjustment 000.020.040.040.040.04
Changes in Working Capital -0-0.020.33-0.760.03-0.690.04
Tax Paid 0000000
Cash Flow From Investing Activity -0.05-0.12-0.190000
Capex -0.05-0.12-0.190000
Net Investments 0000000
Others 0000000
Cash Flow From Financing Activity 0.100.290.081.140.03-0.29-0.02
Net Proceeds from Shares 0.080.2501.35000
Net Proceeds from Borrowing 0000000
Interest Paid 0000000
Dividend Paid 0000000
Others 0.030.040.08-0.210.03-0.29-0.02
Net Cash Flow 00.05-0.0500.04-1.16-0.01
PARTICULARSMar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-27.59-77.28-804.02-97.83-7.53-31.12-11.64
ROCE (%)-19.45-27.62-66.2-53.57-5.23-21.88-7.88
Asset Turnover Ratio000.2600.020.120.36
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days00730500
Inventory Days0025302,65823712
Payable Days0018300125158

Transpact Enterprises Ltd Stock News

Transpact Enterprises Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Transpact Enterprise on 27-Mar-2024 16:01 is ₹394.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Mar-2024 16:01 the market cap of Transpact Enterprise stood at ₹15.24.
The latest P/E ratio of Transpact Enterprise as of 27-Mar-2024 16:01 is 0.00.
The latest P/B ratio of Transpact Enterprise as of 27-Mar-2024 16:01 is 28.58.
The 52-week high of Transpact Enterprise is ₹483.8 and the 52-week low is ₹114.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transpact Enterprise is ₹0.38 ( Cr.) .

About Transpact Enterprises Ltd

Transpact Enterprises

Transpact Enterprises was incorporated as Transpact Enterprises Private Limited on May 12, 2013 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The certificate of incorporation was issued on May 12, 2013 by the Registrar of Companies, Mumbai at Maharashtra. Further the status of the Company was changed to public limited Company and the name of the company was changed to Transpact Enterprises Limited by a special resolution passed on April 10, 2019. A fresh certificate of incorporation consequent to the change of name pursuant to the conversion into public limited company was granted to the Company on April 16, 2019, by the Registrar of Companies, Mumbai.

Business area of the company

Transpact Enterprises, Maharashtra based is a biotechnology startup. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company also offers customized device solutions for patients.

Milestones:

  • May 2013: Incorporated as 'Transpact Enterprises Private Limited'
  • June 2015: Entered license agreement with IIT Bombay to carry out all commercialization related activities of Testibulator
  • December 2015: Filed a patent for the technology of Vestibulator with Controller General of Patents, Designs and Trademarks, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry with IIT Bombay.
  • September 2016: Received ISO 9001:2015 certification for quality management system
  • October 2016: Received 13485:2016 certification for 'Medical devices'.
  • March 2018: Assessed and registered as compliance as per the requirements of Council Directive- Medical Devices Directive– 2007/47/EC by International Standards Registrations.
  • March 2019: Conversion of Private Company ' Transpact Enterprises Private Limited' to Public Company 'Transpact Enterprises Limited'.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.